225 related articles for article (PubMed ID: 11827741)
21. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635.
de Boer SF; Lesourd M; Mocaër E; Koolhaas JM
Neuropsychopharmacology; 2000 Jul; 23(1):20-33. PubMed ID: 10869883
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.
Cryan JF; Kelliher P; Kelly JP; Leonard BE
J Psychopharmacol; 1999; 13(3):278-83. PubMed ID: 10512084
[TBL] [Abstract][Full Text] [Related]
23. Participation of 5-HT(1B) receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5-HT(1B) receptor knockout mice.
Rodríguez-Manzo G; López-Rubalcava C; Hen R; Fernández-Guasti A
Br J Pharmacol; 2002 Aug; 136(8):1127-34. PubMed ID: 12163345
[TBL] [Abstract][Full Text] [Related]
24. 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission.
Parsons LH; Kerr TM; Tecott LH
J Neurochem; 2001 Apr; 77(2):607-17. PubMed ID: 11299323
[TBL] [Abstract][Full Text] [Related]
25. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
Smith BN; Sollars PJ; Dudek FE; Pickard GE
J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
McCreary AC; Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
Cohen ML; Schenck KW; Hemrick-Luecke SH
J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
[TBL] [Abstract][Full Text] [Related]
28. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
29. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
[TBL] [Abstract][Full Text] [Related]
30. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.
Miranda F; Hong E; Sánchez H; Velázquez-Martínez DN
Pharmacol Biochem Behav; 2003 Jan; 74(2):371-80. PubMed ID: 12479957
[TBL] [Abstract][Full Text] [Related]
31. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
[TBL] [Abstract][Full Text] [Related]
32. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
33. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
34. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
[TBL] [Abstract][Full Text] [Related]
35. Effect of a 5-HT(1A) receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats.
Suwabe A; Kubota M; Niwa M; Kobayashi K; Kanba S
Brain Res; 2000 Mar; 858(2):393-401. PubMed ID: 10708692
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
37. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice.
Ase AR; Reader TA; Hen R; Riad M; Descarries L
J Neurochem; 2000 Dec; 75(6):2415-26. PubMed ID: 11080193
[TBL] [Abstract][Full Text] [Related]
38. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice.
Popova NK; Amstislavskaya TG
Psychoneuroendocrinology; 2002 Jul; 27(5):609-18. PubMed ID: 11965359
[TBL] [Abstract][Full Text] [Related]
40. Circadian variation in the activity of the 5-HT(1B) autoreceptor in the region of the suprachiasmatic nucleus, measured by microdialysis in the conscious freely-moving rat.
Garabette ML; Martin KF; Redfern PH
Br J Pharmacol; 2000 Dec; 131(8):1569-76. PubMed ID: 11139433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
